PharmaFocus: HIV - R&D Strategies Towards Cure and Prevention
It has been 30 years since the discovery that HIV is the causative agent of AIDS, and yet no preventative vaccine or cure that allows independence from lifelong antiretroviral treatment exists. Despite some recent setbacks, such as the discontinuation of the HVTN 505 clinical trial due to a trend of increased infection, there have been several promising advances in the cure and prevention of HIV infections. The RV144, a Phase III trial held in Thailand, reduced the risk of infection...
View full press release